Two insiders at Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) submitted Form 4s to the SEC for recent purchases of stock, often considered to be a bullish signal for companies. Since officers and directors of companies have the most complete picture of what is going on inside of their organization, it's a major vote of confidence to see them buying shares.
Insider Buying by the CEO
The Chairman and CEO of Zynerba, Armando Anido, filed a Statement of Changes in Beneficial Ownership (a Form 4) with the SEC on May 16th to report two stock purchases. Mr. Anido made two separate purchases: one on May 12th, and another on May 15th. On May 12th, Mr. Anido purchased 3,500 shares of ZYNE at a weighted average price of $19.76 per share. On May 15th, Mr. Anido purchased an additional 1,500 shares of ZYNE at a weighted average price of $19.57 per share. The combined purchases amount to an investment of $98,515.
Insider Buying by the CFO
The Chief Financial Officer of Zynerba, James Fickenscher, filed a Form 4 with the SEC on May 16th to report a stock purchase. On May 12th, Mr. Fickenscher purchased 5,200 shares of ZYNE at a weighted average price of $19.82 per share. The purchase amounts to an investment of $103,064. Following the purchase, Mr. Fickenscher beneficially owns 12,200 shares of ZYNE.
To learn more about Zynerba Pharmaceuticals, Inc. be sure to check out the company's profile in our marijuana stocks database. To check out other companies operating in the cannabinoid-biotech space, check out our sector database.
Also, be sure to subscribe to one or more of our free newsletters so you never miss an important update. If you haven't already, connect with The Daily Marijuana Observer on Facebook, Twitter, and Instagram.
I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
I have no business relationship with any company whose stock is mentioned in this article.
The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.